• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Interpreting global trends in type 2 diabetes complications and mortality.解读 2 型糖尿病并发症和死亡率的全球趋势。
Diabetologia. 2022 Jan;65(1):3-13. doi: 10.1007/s00125-021-05585-2. Epub 2021 Nov 27.
2
Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.2015 年全球、区域和国家外周动脉疾病的患病率和风险因素:更新的系统评价和分析。
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030. doi: 10.1016/S2214-109X(19)30255-4.
3
Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates.全球 109 个国家 2000 年至 2014 年因低血糖相关死亡的负担:基于死亡证明的分析。
Diabetologia. 2018 Jul;61(7):1592-1602. doi: 10.1007/s00125-018-4626-y. Epub 2018 May 1.
4
Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications.糖尿病作为心血管风险因素:宏观和微观血管并发症全球趋势概述。
Eur J Prev Cardiol. 2019 Dec;26(2_suppl):25-32. doi: 10.1177/2047487319878371. Epub 2019 Nov 13.
5
Tuberculosis结核病
6
Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model.在中低收入国家增加对糖尿病及其相关心血管风险因素的诊断、治疗和控制的估计效果:一个微观模拟模型。
Lancet Glob Health. 2021 Nov;9(11):e1539-e1552. doi: 10.1016/S2214-109X(21)00340-5. Epub 2021 Sep 22.
7
The changing face of diabetes complications.糖尿病并发症的变化面貌。
Lancet Diabetes Endocrinol. 2016 Jun;4(6):537-47. doi: 10.1016/S2213-8587(16)30010-9. Epub 2016 May 4.
8
Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults.57个低收入和中等收入国家的体重指数与糖尿病风险:一项基于685616名成年人全国代表性个体水平数据的横断面研究
Lancet. 2021 Jul 17;398(10296):238-248. doi: 10.1016/S0140-6736(21)00844-8.
9
Global trends in diabetes complications: a review of current evidence.全球糖尿病并发症趋势:现有证据综述。
Diabetologia. 2019 Jan;62(1):3-16. doi: 10.1007/s00125-018-4711-2. Epub 2018 Aug 31.
10
Cardiovascular disease in diabetes type 2: current concepts.2 型糖尿病中的心血管疾病:当前概念。
J Intern Med. 2018 Sep;284(3):240-253. doi: 10.1111/joim.12804. Epub 2018 Jul 18.

引用本文的文献

1
Efficacy of stem cell therapy for diabetic kidney disease: a systematic review and meta-analysis.干细胞疗法治疗糖尿病肾病的疗效:一项系统评价和荟萃分析。
Front Med (Lausanne). 2025 Sep 1;12:1601900. doi: 10.3389/fmed.2025.1601900. eCollection 2025.
2
Health state utility values and associated complication-related difference in community-based adults with type 2 diabetes in Nanjing China: a cross-sectional study.中国南京社区2型糖尿病成年患者的健康状态效用值及相关并发症差异:一项横断面研究
Front Med (Lausanne). 2025 Aug 26;12:1599857. doi: 10.3389/fmed.2025.1599857. eCollection 2025.
3
Identification of gene-sex hormone interactions associated with type 2 diabetes among men and women.男性和女性中与2型糖尿病相关的基因-性激素相互作用的鉴定。
PLoS Genet. 2025 Sep 2;21(9):e1011470. doi: 10.1371/journal.pgen.1011470. eCollection 2025 Sep.
4
Systemic Immune-Inflammation Index and Related Hematologic Markers as Prognostic Tools in Type 2 Diabetes.全身免疫炎症指数及相关血液学标志物作为2型糖尿病的预后评估工具
Medicina (Kaunas). 2025 Aug 9;61(8):1433. doi: 10.3390/medicina61081433.
5
The Experience of Fear of Complications Among Patients with Type 2 Diabetes Mellitus: A Qualitative Study.2型糖尿病患者对并发症恐惧的体验:一项定性研究。
Patient Prefer Adherence. 2025 Aug 20;19:2553-2563. doi: 10.2147/PPA.S536379. eCollection 2025.
6
The efficacy of saffron supplementation on inflammation and oxidative stress in patients with type-2 diabetes mellitus: a meta-analysis.藏红花补充剂对2型糖尿病患者炎症和氧化应激的疗效:一项荟萃分析。
Front Endocrinol (Lausanne). 2025 Aug 6;16:1634982. doi: 10.3389/fendo.2025.1634982. eCollection 2025.
7
Novel Lipid Biomarkers and Microvascular Complications in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysis.糖尿病患者的新型脂质生物标志物与微血管并发症:一项系统评价和荟萃分析
Clin Med Insights Endocrinol Diabetes. 2025 Aug 16;18:11795514251365301. doi: 10.1177/11795514251365301. eCollection 2025.
8
Data-driven cluster analysis on the association of aging, obesity and insulin resistance with new-onset diabetes in Chinese adults: a multicenter retrospective cohort study.中国成年人中衰老、肥胖和胰岛素抵抗与新发糖尿病关联的数据驱动聚类分析:一项多中心回顾性队列研究
Front Med (Lausanne). 2025 Jul 30;12:1640017. doi: 10.3389/fmed.2025.1640017. eCollection 2025.
9
Effects of Probiotic and Synbiotic Supplementation on Glycemic Indices in Adult Individuals with Prediabetes and Type 2 Diabetes Mellitus: A Grade-Assessed Systematic Review and Dose-Response Meta-analysis of RCTs.补充益生菌和合生元对糖尿病前期和2型糖尿病成年个体血糖指数的影响:一项基于等级评估的随机对照试验系统评价和剂量反应荟萃分析
Probiotics Antimicrob Proteins. 2025 Aug 9. doi: 10.1007/s12602-025-10644-w.
10
Establishment and validation of a risk prediction model for urinary tract infection in elderly patients with type 2 diabetes mellitus.2型糖尿病老年患者尿路感染风险预测模型的建立与验证
Front Endocrinol (Lausanne). 2025 Jul 23;16:1557185. doi: 10.3389/fendo.2025.1557185. eCollection 2025.

本文引用的文献

1
The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults.55 个低收入和中等收入国家糖尿病治疗覆盖情况的现状:680102 名成年人的全国代表性个体水平数据的横断面研究。
Lancet Healthy Longev. 2021 Jun;2(6):e340-e351. doi: 10.1016/s2666-7568(21)00089-1. Epub 2021 May 21.
2
Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018.美国成年人糖尿病治疗和控制的趋势,1999-2018 年。
N Engl J Med. 2021 Jun 10;384(23):2219-2228. doi: 10.1056/NEJMsa2032271.
3
Trends in Receipt of American Diabetes Association Guideline-Recommended Care Among U.S. Adults With Diabetes: NHANES 2005-2018.美国成年人糖尿病患者接受美国糖尿病协会指南推荐治疗的趋势:NHANES 2005-2018 年。
Diabetes Care. 2021 Jun;44(6):1300-1308. doi: 10.2337/dc20-2541. Epub 2021 Apr 16.
4
Diabetes mellitus hospitalization and mortality rate according to a national database in Brazil: a longitudinal study.根据巴西国家数据库得出的糖尿病住院率和死亡率:一项纵向研究。
BMC Public Health. 2021 Feb 25;21(1):403. doi: 10.1186/s12889-021-10438-z.
5
Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records.2001 年至 2018 年英格兰有和无糖尿病患者主要死亡原因的趋势:基于关联初级保健记录的流行病学分析。
Lancet Diabetes Endocrinol. 2021 Mar;9(3):165-173. doi: 10.1016/S2213-8587(20)30431-9. Epub 2021 Feb 4.
6
Trends in diabetes mortality identified from death certificates in Colombia, 1979-2017.1979 - 2017年哥伦比亚死亡证明中确定的糖尿病死亡率趋势。
Rev Panam Salud Publica. 2021 Jan 15;45:e13. doi: 10.26633/RPSP.2021.13. eCollection 2021.
7
Temporal Trends in Incidence Rates of Lower Extremity Amputation and Associated Risk Factors Among Patients Using Veterans Health Administration Services From 2008 to 2018.2008年至2018年使用退伍军人健康管理局服务的患者下肢截肢发病率的时间趋势及相关风险因素
JAMA Netw Open. 2021 Jan 4;4(1):e2033953. doi: 10.1001/jamanetworkopen.2020.33953.
8
Declining mortality in older people with type 2 diabetes masks rising excess risks at younger ages: a population-based study of all-cause and cause-specific mortality over 13 years.2 型糖尿病老年患者死亡率的下降掩盖了年轻患者超额风险的上升:一项基于人群的全因和死因特异性死亡率研究,随访时间为 13 年。
Int J Epidemiol. 2021 Aug 30;50(4):1362-1372. doi: 10.1093/ije/dyaa270.
9
Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes.美国新诊断 2 型糖尿病成年人并发症 30 年趋势。
Diabetes Care. 2021 Mar;44(3):699-706. doi: 10.2337/dc20-2304. Epub 2021 Jan 8.
10
Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes.在确诊为 2 型糖尿病的患者中,15 年内微血管和大血管并发症的患病率和发生率。
BMJ Open Diabetes Res Care. 2021 Jan;9(1). doi: 10.1136/bmjdrc-2020-001847.

解读 2 型糖尿病并发症和死亡率的全球趋势。

Interpreting global trends in type 2 diabetes complications and mortality.

机构信息

Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, GA, USA.

出版信息

Diabetologia. 2022 Jan;65(1):3-13. doi: 10.1007/s00125-021-05585-2. Epub 2021 Nov 27.

DOI:10.1007/s00125-021-05585-2
PMID:34837505
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8660730/
Abstract

International trends in traditional diabetes complications (cardiovascular, renal, peripheral vascular, ophthalmic, hepatic or neurological diseases) and mortality rates are poorly characterised. An earlier review of studies published up to 2015 demonstrated that most data come from a dozen high-income countries (HICs) in North America, Europe or the Asia-Pacific region and that, in these countries at least, rates of acute glycaemic fluctuations needing medical attention and amputations, myocardial infarction and mortality were all declining over the period. Here, we provide an updated review of published literature on trends in type 2 diabetes complications and mortality in adults since 2015. We also discuss issues related to data collection, analysis and reporting that have influenced global trends in type 2 diabetes and its complications. We found that most data on trends in type 2 diabetes, its complications and mortality come from a small number of HICs with comprehensive surveillance systems, though at least some low- and middle-income countries (LMICs) from Africa and Latin America are represented in this review. The published data suggest that HICs have experienced declines in cardiovascular complication rates and all-cause mortality in people with diabetes. In parallel, cardiovascular complications and mortality rates in people with diabetes have increased over time in LMICs. However, caution is warranted in interpreting trends from LMICs due to extremely sparse data or data that are not comparable across countries. We noted that approaches to case ascertainment and definitions of complications and mortality (numerators) and type 2 diabetes (the denominator) vary widely and influence the interpretation of international data. We offer four key recommendations to more rigorously document trends in rates of type 2 diabetes complications and mortality, over time and worldwide: (1) increasing investments in data collection systems; (2) standardising case definitions and approaches to ascertainment; (3) strengthening analytical capacity; and (4) developing and implementing structured guidelines for reporting of data.

摘要

国际上传统糖尿病并发症(心血管、肾脏、周围血管、眼科、肝脏或神经系统疾病)和死亡率趋势的特征描述较差。对截至 2015 年发表的研究进行的早期综述表明,大多数数据来自北美、欧洲或亚太地区十几个高收入国家(HICs),至少在这些国家,需要医疗关注的急性血糖波动、截肢、心肌梗死和死亡率的发生率在这期间都呈下降趋势。在这里,我们对 2015 年以来成年人 2 型糖尿病并发症和死亡率的已发表文献进行了更新综述。我们还讨论了与数据收集、分析和报告相关的问题,这些问题影响了 2 型糖尿病及其并发症的全球趋势。我们发现,大多数关于 2 型糖尿病、其并发症和死亡率趋势的数据来自少数具有综合监测系统的 HICs,但至少有一些来自非洲和拉丁美洲的低收入和中等收入国家(LMICs)也参与了这项研究。已发表的数据表明,HICs 经历了心血管并发症发生率和糖尿病患者全因死亡率的下降。与此同时,随着时间的推移,糖尿病患者的心血管并发症和死亡率在 LMICs 中不断上升。然而,由于数据极其稀疏或各国之间的数据不可比,因此在解释来自 LMICs 的趋势时需要谨慎。我们注意到,病例确定方法以及并发症和死亡率(分子)和 2 型糖尿病(分母)的定义差异很大,这影响了对国际数据的解释。我们提出了四项关键建议,以更严格地记录全球范围内 2 型糖尿病并发症和死亡率的趋势:(1)增加对数据收集系统的投资;(2)标准化病例定义和确定方法;(3)加强分析能力;(4)制定和实施数据报告的结构化指南。